Merck
-
Could the Moderna-Merck Melanoma Vaccine Win FDA Approval Within Two Years? What We Know
Intismeran met primary endpoints in phase 3, but FDA filing date remains unannounced as companies race toward potential 2027 approval.
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
The numbers first: 1,137 patients, split two to one, all with melanoma that surgeons had already removed. On Wednesday, 19 August 2026,…
-
Merck and Moderna Report Phase 3 Win for mRNA Melanoma Therapy Plus Keytruda
New York, August 20 — Merck and Moderna announced successful results from a late-stage clinical trial for an mRNA-based cancer vaccine targeting…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Bacteria Pair Cleared Tumours in Mice in 2025 Study; Not Yet Tested in People
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Sacituzumab Tirumotecan Boosts Survival in Advanced Gastroesophageal Cancer
-
FDA approves Novo Nordisk’s Sogroya as first weekly growth hormone for Turner syndrome
-
Blood Biomarker eMTBR-tau243 Detects Advanced CTE in Living Patients
-
Cemdisiran Cuts Dosing to Four Shots a Year in Myasthenia Gravis
-
AbbVie Bets $2.5 Billion on DISCO’s Bispecific Platform to Expand Oncology Pipeline
-
How to Pay Down Credit Card Debt Before Holiday Spending Peaks
-
Small Business Sale Can Trigger Up to 37% Federal Tax, New Data Shows
-
Annuity Renewal Traps: How Automatic Rollovers Lock Retirees Into Lower Rates
-
How Fed Cuts, Bank Competition and Deposit Insurance Could Crash High-Yield Savings Rates
-
How 401(k) Holders Can Automatically Cut Single-Stock Concentration Risk
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992



